AstraZeneca (AZN)

Add to Watchlists
Create an Alert
65.41 +0.77  +1.19% NYSE Jul 2, 8:00PM Delayed 2m USD

AstraZeneca Cash from Financing (TTM):

-3.062B for March 31, 2015

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Financing (TTM) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Financing (TTM) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2015 -3.062B
Dec. 31, 2014 -2.705B
Sept. 30, 2014 -3.655B
June 30, 2014 -3.481B
March 31, 2014 -3.027B
Dec. 31, 2013 -3.047B
Sept. 30, 2013 -3.773B
June 30, 2013 -2.903B
March 31, 2013 -3.717B
Dec. 31, 2012 -4.923B
Sept. 30, 2012 -6.079B
June 30, 2012 -8.687B
March 31, 2012 -8.952B
Dec. 31, 2011 -9.321B
Sept. 30, 2011 -9.46B
June 30, 2011 -8.341B
March 31, 2011 -7.803B
Dec. 31, 2010 -7.334B
Sept. 30, 2010 -5.45B
June 30, 2010 -5.189B
March 31, 2010 -4.713B
Dec. 31, 2009 -3.629B
Sept. 30, 2009 -5.193B
June 30, 2009 -6.031B
March 31, 2009 -6.235B
   
Dec. 31, 2008 -6.362B
Sept. 30, 2008 -5.065B
June 30, 2008 -5.668B
March 31, 2008 6.709B
Dec. 31, 2007 6.051B
Sept. 30, 2007 5.096B
June 30, 2007 6.122B
March 31, 2007 -6.763B
Dec. 31, 2006 -5.366B
Sept. 30, 2006 -4.965B
June 30, 2006 -4.678B
March 31, 2006 -4.656B
Dec. 31, 2005 -4.572B
Sept. 30, 2005 -4.456B
June 30, 2005 -3.914B
March 31, 2005 -3.739B
Dec. 31, 2004 -2.761B
Sept. 30, 2004 -3.523B
June 30, 2004 -2.851B
March 31, 2004 -3.125B
Dec. 31, 2003 -2.674B
Sept. 30, 2003 -2.892B
June 30, 2003 -2.136B
March 31, 2003 -3.308B
Dec. 31, 2002 -3.312B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Advertisement

AZN Cash from Financing (TTM) Benchmarks

Companies
Bristol-Myers Squibb -1.927B
GlaxoSmithKline -7.288B
Johnson & Johnson -12.43B

AZN Cash from Financing (TTM) Range, Past 5 Years

Minimum -9.46B Sep 2011
Maximum -2.705B Dec 2014
Average -5.564B

AZN Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("AZN", "cash_financing_ttm")
  • Last 5 data points: =YCS("AZN", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.